Studies have shown that MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p [18], the MORC2-mutant M276I promotes metastasis of triple-negative breast cancer by regulating CD44 splicing [13]. This evidence concerns the gene MORC2 and cholangiocarcinoma.